English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Multicenter studies on breast cancer require inter-institutional collaboration, resources and specialized personnel. In Mexico, many institutions provide these services, but their information is not accessible; to mitigate it, the Mexican Society of Oncology formed the Mexican Cooperative Research Groups in Oncology. Objective: To describe the infrastructure, personnel and activities of hospitals with care of patients with breast cancer in Mexico. Methods: A survey was conducted to 30 breast cancer specialists about resources and services of their institutions. Results: 13  (43.3%) specialists answered the survey, 38.5% of Seguro Popular, 23.1% of Instituto Mexicano del Seguro Social, and 38.4% of other institutions, with a median of 300  (50-950) new cases per year. All the institutions have oncological surgery, breast radiology, palliative care, pathology, nutrition and multidisciplinary sessions. All have ultrasound with breast transducer, 92.3% digital mammography, and 53.8% tomosynthesis and/or magnetic resonance. They do sentinel lymph node detection with dye (92.3%) or radionuclide (61.5%). Tamoxifen, aromatase inhibitors and trastuzumab are available in 92.3%, and other target therapies in < 40%. Genetic signatures are done in 21.3% and 61.5% analysis of hereditary cancer. Conclusions: The institutional capacity to participate in multicenter studies is heterogeneous; the few resources in several institutions limit their inclusion to studies of breast cancer.

Resources for the attention of patients with breast cancer in Mexico